Mechanism of Action of Alpha-Glucosidase Inhibitors

Introduction

Alpha-glucosidase inhibitors are oral antidiabetic agents that reduce postprandial hyperglycemia by delaying carbohydrate digestion and glucose absorption in the intestine. These drugs are especially effective when taken with meals rich in complex carbohydrates.

Commonly used agents include:

• Acarbose
• Miglitol

Unlike insulin-dependent agents, they work locally in the gut and have no direct effect on insulin secretion, making them safe in elderly and those with mild hyperglycemia.

---

Stepwise Mechanism of Action of Alpha-Glucosidase Inhibitors

1. Site of action – Small intestine
   These drugs act on the brush border of the small intestine, where disaccharides and complex carbs are broken down.
2. Inhibition of alpha-glucosidase enzymes
   They inhibit alpha-glucosidase, an enzyme that converts complex carbohydrates into absorbable monosaccharides (glucose).
3. Delayed carbohydrate digestion
   As a result, glucose absorption is slowed, leading to less post-meal glucose spikes.
4. Decreased postprandial hyperglycemia
   The reduced rate of carbohydrate digestion blunts the rise in blood glucose after meals, especially in combination therapy.
5. No insulin release stimulation
   These agents do not affect pancreatic beta cells, so they do not cause hypoglycemia when used alone.

---

Pharmacokinetic Parameters of Alpha-Glucosidase Inhibitors

Drug	Absorption	Metabolism	Excretion
Acarbose	Minimal	Intestinal bacteria	Fecal (~50%), Renal
Miglitol	Good	Not metabolized	Renal (unchanged)

---

Clinical Uses of Alpha-Glucosidase Inhibitors

• Type 2 diabetes mellitus (especially postprandial hyperglycemia)
• Combined with sulfonylureas, metformin, or insulin
• Beneficial in patients with mild diabetes, elderly, or those consuming high-carb diets

---

Adverse Effects of Alpha-Glucosidase Inhibitors

• Flatulence (gas) – due to fermentation of undigested carbs
• Abdominal bloating and cramping
• Diarrhea
• Elevated liver enzymes (with high doses of acarbose)
• Hypoglycemia – only when combined with insulin or sulfonylureas
  → Note: Must treat with glucose, not sucrose

---

Comparative Analysis: Acarbose vs Miglitol

Feature	Acarbose	Miglitol
Absorption	Poor (local action)	Well absorbed
Excretion	Fecal + renal	Renal (unchanged)
GI side effects	More common	Less severe
Hypoglycemia risk	Only in combinations	Only in combinations
Dose timing	With meals	With meals

---

Practice MCQs

Q1. Alpha-glucosidase inhibitors lower blood sugar by:
a. Enhancing insulin secretion
b. Blocking renal glucose reabsorption
c. Inhibiting intestinal carbohydrate digestion ✅
d. Stimulating GLUT4

Q2. The main site of action of these drugs is:
a. Stomach
b. Liver
c. Small intestine (brush border) ✅
d. Kidney

Q3. Which enzyme do alpha-glucosidase inhibitors block?
a. Alpha-amylase
b. Alpha-glucosidase ✅
c. Lactase
d. Protease

Q4. Which of the following is NOT an expected side effect?
a. Flatulence
b. Abdominal cramps
c. Hypoglycemia when used alone ✅
d. Diarrhea

Q5. Which of the following must be used to treat hypoglycemia caused during combination therapy?
a. Sucrose
b. Glucose ✅
c. Honey
d. Bread

Q6. Miglitol differs from acarbose by:
a. Being poorly absorbed
b. Being metabolized in the liver
c. Being fully absorbed and renally excreted ✅
d. Causing more flatulence

Q7. Which patient group benefits most from these drugs?
a. Those with fasting hyperglycemia
b. Those with postprandial hyperglycemia ✅
c. Type 1 diabetics
d. Gestational diabetics

Q8. What should patients avoid while on acarbose?
a. Fatty meals
b. Alcohol
c. Sucrose for hypoglycemia ✅
d. Salt

Q9. What causes gas and bloating in patients on these drugs?
a. Poor digestion
b. Bacterial fermentation of undigested carbs ✅
c. Insulin release
d. Gastrin stimulation

Q10. When should alpha-glucosidase inhibitors be taken?
a. Before bedtime
b. On an empty stomach
c. 30 minutes after meals
d. With the first bite of meals ✅

---

FAQs

Q1: Do alpha-glucosidase inhibitors cause hypoglycemia?
Not when used alone. Risk arises only when combined with sulfonylureas or insulin.

Q2: Are they effective in fasting hyperglycemia?
They primarily reduce postprandial spikes, not fasting glucose.

Q3: Can these drugs be used in renal failure?
Use with caution. Miglitol is renally excreted, and dose adjustment is needed.

Q4: What is the key side effect to counsel patients on?
Flatulence and GI discomfort are common and often limit adherence.

---

References

• KD Tripathi – Essentials of Medical Pharmacology
• Goodman & Gilman – The Pharmacological Basis of Therapeutics
• Review of Pharmacology – Sparsh Gupta
• ADA Guidelines
• NCBI: https://www.ncbi.nlm.nih.gov/books/NBK558975/